Skip to main content
Erschienen in: Journal of Cancer Education 4/2021

04.01.2020

Melanoma Awareness Among Medical Students

verfasst von: L. L. Kalil, E. H. M. Prado, R. V. U. Resende, M. R. C. Pimenta, A. J. A. Wainstein, A. P. Drummond-Lage

Erschienen in: Journal of Cancer Education | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Melanoma is the most aggressive skin cancer. Since diagnosis is visual, it is critical to evaluate if students acquire enough knowledge for early detection during medical school. To assess the melanoma knowledge of first-year (freshman) and sixth-year (senior) medical students, in a Brazilian Institution. It was a transversal and quantitative study. A questionnaire with sociodemographic data, knowledge about melanoma, and the habit of skin self-exam was filled out by medical students. A total of 128 first-year and 122 seniors students were included. All the sixth-year students knew melanoma as a skin cancer compared with 46.09% of the first-year students. Melanoma clinical characteristics were known by 30.51% of the freshman and 97.54% of seniors. However, they did not know the most usual site of melanoma occurrence (79.66% of first-year students and 24.59% of senior). About the skin self-exam, only 50% of first-year students and 53.28% of senior had the habit of doing it sometimes. Medical school was effective in providing knowledge about melanoma and its features. However, this was not reflected in an increase in the number of students that did the skin self-exam, which indicates the need for new approaches in teaching.
Literatur
1.
Zurück zum Zitat Instituto Nacional de Câncer. Tipos de câncer: pele melanoma. [Accessed: 26 September 2019] Instituto Nacional de Câncer. Tipos de câncer: pele melanoma. [Accessed: 26 September 2019]
2.
Zurück zum Zitat Vazquez VL, Silva TB, Vieira MA, de Oliveira ATT, Lisboa MV, de Andrade DAP et al (2015) Melanoma characteristics in Brazil: demographics, treatment, and survival analysis. BMC Research Notes 8(1):4CrossRef Vazquez VL, Silva TB, Vieira MA, de Oliveira ATT, Lisboa MV, de Andrade DAP et al (2015) Melanoma characteristics in Brazil: demographics, treatment, and survival analysis. BMC Research Notes 8(1):4CrossRef
3.
Zurück zum Zitat World Health Organization. Estimated number of new cases in 2018, worldwide, both sexes, all ages. Global Health Observatory. [Accessed: 26 September 2019] World Health Organization. Estimated number of new cases in 2018, worldwide, both sexes, all ages. Global Health Observatory. [Accessed: 26 September 2019]
4.
Zurück zum Zitat Houghton AN, Polsky D (2002) Focus on melanoma. Cancer Cell 2(4):275–278CrossRef Houghton AN, Polsky D (2002) Focus on melanoma. Cancer Cell 2(4):275–278CrossRef
5.
Zurück zum Zitat Erdei E, Torres SM (2010) A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther 10(11):1811–1823CrossRef Erdei E, Torres SM (2010) A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther 10(11):1811–1823CrossRef
6.
Zurück zum Zitat Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR et al (2009) Final version of 2009 AJCC melanoma staging and classification. JournalofClinicalOncology. 27(36):6199–6206 Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR et al (2009) Final version of 2009 AJCC melanoma staging and classification. JournalofClinicalOncology. 27(36):6199–6206
7.
Zurück zum Zitat Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur G, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform (2017) Melanoma staging: evidence-based changes in the American Joint CommitteeonCancereightheditioncancerstaging manual. CA Cancer J Clin 67(6):472–492CrossRef Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur G, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform (2017) Melanoma staging: evidence-based changes in the American Joint CommitteeonCancereightheditioncancerstaging manual. CA Cancer J Clin 67(6):472–492CrossRef
8.
Zurück zum Zitat American CancerSociety. Cancerfacts& figures. [Accessed: 26 September 2019] American CancerSociety. Cancerfacts& figures. [Accessed: 26 September 2019]
9.
Zurück zum Zitat Datafolha, Instituto de Pesquisa; Conhecimento Melanoma. [Accessed: 26 September 2019] Datafolha, Instituto de Pesquisa; Conhecimento Melanoma. [Accessed: 26 September 2019]
10.
Zurück zum Zitat Gomes TM, Moura ATMS, Aguiar AC (2012) Dermatologia na atenção primária: um desafio para a formação e prática médica. Revista Brasileira de EducaçãoMédica 36(1):125–128CrossRef Gomes TM, Moura ATMS, Aguiar AC (2012) Dermatologia na atenção primária: um desafio para a formação e prática médica. Revista Brasileira de EducaçãoMédica 36(1):125–128CrossRef
11.
Zurück zum Zitat Nahar VK, Wilkerson AH, Ghafari G, Martin B, Black WH, Boyas JF, Savoy M, Bawa G, Stafford FC Jr, Scott M, Grigsby TB, Gromley Z, Grant-Kels JM, Brodell RT (2018) Skin cancer knowledge, attitudes, beliefs, and prevention practices among medical students: a systematic search and literature review. International Journal of Women’s Dermatology 4(3):139–149CrossRef Nahar VK, Wilkerson AH, Ghafari G, Martin B, Black WH, Boyas JF, Savoy M, Bawa G, Stafford FC Jr, Scott M, Grigsby TB, Gromley Z, Grant-Kels JM, Brodell RT (2018) Skin cancer knowledge, attitudes, beliefs, and prevention practices among medical students: a systematic search and literature review. International Journal of Women’s Dermatology 4(3):139–149CrossRef
12.
Zurück zum Zitat Youl PH, Baade PD, Janda M, Del Mar CB, Whiteman DC, Aitken JF (2007) Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary care skin cancer clinic doctors? Med J Aust 187(4):215–220CrossRef Youl PH, Baade PD, Janda M, Del Mar CB, Whiteman DC, Aitken JF (2007) Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary care skin cancer clinic doctors? Med J Aust 187(4):215–220CrossRef
13.
Zurück zum Zitat Grupo Brasileiro de Melanoma. Melanoma cutâneo: você pode reconhecer os sinais. [Accessed: 26 September 2019] Grupo Brasileiro de Melanoma. Melanoma cutâneo: você pode reconhecer os sinais. [Accessed: 26 September 2019]
14.
Zurück zum Zitat Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Jonhson TM (2002) Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 95(7):1562–1568CrossRef Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Jonhson TM (2002) Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 95(7):1562–1568CrossRef
15.
Zurück zum Zitat Xavier MH, Drummond-Lage AP, Baeta C, Rocha L, Almeida AM, Wainstein AJ (2016 Aug) Delay in cutaneous melanoma diagnosis: sequence analyses from suspicion to diagnosis in 211 patients. Medicine (Baltimore) 95(31):e4396CrossRef Xavier MH, Drummond-Lage AP, Baeta C, Rocha L, Almeida AM, Wainstein AJ (2016 Aug) Delay in cutaneous melanoma diagnosis: sequence analyses from suspicion to diagnosis in 211 patients. Medicine (Baltimore) 95(31):e4396CrossRef
16.
Zurück zum Zitat De Melo AC, Wainstein AJ, Buzaid AC, Thuler LCS (2018) Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res 28(6):629–636CrossRef De Melo AC, Wainstein AJ, Buzaid AC, Thuler LCS (2018) Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res 28(6):629–636CrossRef
17.
Zurück zum Zitat Ivanov NN, Swan A, Guseman EH, Whipps J, Jensen LL, Beverly EA (2018) Medical students’ knowledge, attitudes, and behaviors with regard to skin cancer and sun-protective behaviors. The Journal of the American OsteopathicAssociation 118(7):444–454 Ivanov NN, Swan A, Guseman EH, Whipps J, Jensen LL, Beverly EA (2018) Medical students’ knowledge, attitudes, and behaviors with regard to skin cancer and sun-protective behaviors. The Journal of the American OsteopathicAssociation 118(7):444–454
Metadaten
Titel
Melanoma Awareness Among Medical Students
verfasst von
L. L. Kalil
E. H. M. Prado
R. V. U. Resende
M. R. C. Pimenta
A. J. A. Wainstein
A. P. Drummond-Lage
Publikationsdatum
04.01.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01685-1

Weitere Artikel der Ausgabe 4/2021

Journal of Cancer Education 4/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.